Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Hair pain is more common in women with hair loss, but it's not linked to the cause or severity of hair loss.

Excess androgens may cause PCOS, not just be a symptom.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Neutered ferrets often develop hyperadrenocorticism, with symptoms like hair loss and lethargy, and androstenedione is a key indicator for diagnosis.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

Women with Female Pattern Hair Loss may experience more stress, anxiety, and depression, and have lower levels of BDNF, which could predict the psychological impact.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

Adolescents with hair loss show different hormone levels by sex and often have related metabolic issues.

COVID-19 can cause various skin issues, with some linked to how severe the illness is.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Hair loss can lead to significant stigma and lower quality of life, especially for women and those with certain types of alopecia.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

PAD is common but often missed, needing lifestyle changes and medication for better outcomes.

Higher substance P levels may cause discomfort in hair loss patients.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.